{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "17720709",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20200714",
      "reporttype": "1",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20200428",
      "receiptdateformat": "102",
      "receiptdate": "20200428",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-ROCHE-2407564",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "ROCHE",
        "duplicatenumb": "US-ROCHE-2407564"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientweight": "72.64",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "23.0",
            "reactionmeddrapt": "Dizziness",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "AVASTIN",
            "drugbatchnumb": "UNKNOWN",
            "drugauthorizationnumb": "125085",
            "drugdosagetext": "25 MG/M",
            "drugdosageform": "SOLUTION FOR INFUSION",
            "drugadministrationroute": "065",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "actiondrug": "5",
            "drugadditional": "3",
            "activesubstance": {
              "activesubstancename": "BEVACIZUMAB"
            },
            "openfda": {
              "application_number": [
                "BLA125085"
              ],
              "brand_name": [
                "AVASTIN"
              ],
              "generic_name": [
                "BEVACIZUMAB"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "50242-060",
                "50242-061"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "BEVACIZUMAB"
              ],
              "rxcui": [
                "1657066",
                "1657068",
                "1657073",
                "1657074"
              ],
              "spl_id": [
                "8debebf6-af94-4ba7-8d67-c801f4ea27eb"
              ],
              "spl_set_id": [
                "939b5d1f-9fb2-4499-80ef-0607aa6b114e"
              ],
              "package_ndc": [
                "50242-060-01",
                "50242-060-10",
                "50242-061-01",
                "50242-061-10"
              ],
              "nui": [
                "N0000193543",
                "N0000178291",
                "N0000193542"
              ],
              "pharm_class_epc": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]"
              ],
              "unii": [
                "2S9ZZM9Q9V"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VITAMIN D3",
            "drugdosagetext": "1000 UNIT",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "CHOLECALCIFEROL"
            },
            "openfda": {
              "application_number": [
                "ANDA090455"
              ],
              "brand_name": [
                "VITAMIN D"
              ],
              "generic_name": [
                "ERGOCALCIFEROL"
              ],
              "manufacturer_name": [
                "Strides Pharma Science Limited"
              ],
              "product_ndc": [
                "64380-737"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ERGOCALCIFEROL"
              ],
              "rxcui": [
                "1367410"
              ],
              "spl_id": [
                "1cc589f7-cd6d-40a6-8fce-c965e8945eae"
              ],
              "spl_set_id": [
                "2c4c0a36-12cf-444d-9d57-de983eef4d36"
              ],
              "package_ndc": [
                "64380-737-06",
                "64380-737-25"
              ],
              "nui": [
                "M0007651",
                "N0000175909"
              ],
              "pharm_class_cs": [
                "Ergocalciferols [CS]"
              ],
              "pharm_class_epc": [
                "Provitamin D2 Compound [EPC]"
              ],
              "unii": [
                "VS041H42XC"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "LONSURF",
            "drugbatchnumb": "UNKNOWN",
            "drugindication": "COLON CANCER METASTATIC",
            "actiondrug": "5",
            "drugadditional": "3",
            "activesubstance": {
              "activesubstancename": "TIPIRACIL HYDROCHLORIDE\\TRIFLURIDINE"
            },
            "openfda": {
              "application_number": [
                "NDA207981"
              ],
              "brand_name": [
                "LONSURF"
              ],
              "generic_name": [
                "TRIFLURIDINE AND TIPIRACIL"
              ],
              "manufacturer_name": [
                "Taiho Pharmaceutical Co., Ltd."
              ],
              "product_ndc": [
                "64842-1020",
                "64842-1025"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "TRIFLURIDINE",
                "TIPIRACIL HYDROCHLORIDE"
              ],
              "rxcui": [
                "1670311",
                "1670316",
                "1670322",
                "1670324"
              ],
              "spl_id": [
                "15b86e86-8940-44e3-921c-2e0b97180ea1"
              ],
              "spl_set_id": [
                "f5beed22-d71d-4c0d-8dca-2c7317d65d85"
              ],
              "package_ndc": [
                "64842-1025-1",
                "64842-1025-2",
                "64842-1025-3",
                "64842-1020-1",
                "64842-1020-2",
                "64842-1020-3"
              ],
              "nui": [
                "N0000175459",
                "N0000175466",
                "N0000175595",
                "N0000000233"
              ],
              "pharm_class_epc": [
                "Nucleoside Analog Antiviral [EPC]",
                "Nucleoside Metabolic Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Nucleic Acid Synthesis Inhibitors [MoA]"
              ],
              "unii": [
                "4H59KLQ0A4",
                "RMW9V5RW38"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MORPHINE SULPHATE",
            "drugstructuredosagenumb": "15",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "MORPHINE SULFATE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SENNA S",
            "drugstructuredosagenumb": "8.6",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DOCUSATE SODIUM\\SENNA LEAF"
            },
            "openfda": {
              "application_number": [
                "505G(a)(3)",
                "M007"
              ],
              "brand_name": [
                "SENNA S"
              ],
              "generic_name": [
                "DOCUSATE SODIUM, SENNOSIDES",
                "DOCUSATE SODIUM AND SENNOSIDES",
                "SENNOSIDES AND DOCUSATE SODIUM",
                "DOCUSATE SODIUM SENNOSIDES"
              ],
              "manufacturer_name": [
                "TOP CARE (Topco Associates LLC)",
                "Walgreens",
                "Safeway, Inc.",
                "Shield Pharmaceuticals Corp",
                "Marlex Pharmaceuticals Inc",
                "Medline Industries, LP",
                "Magno-Humphries, Inc.",
                "QUALITY CHOICE (Chain Drug Marketing Association)",
                "United Natural Foods, Inc. dba UNFI"
              ],
              "product_ndc": [
                "36800-783",
                "0363-0883",
                "21130-883",
                "83059-0120",
                "10135-669",
                "53329-989",
                "54257-089",
                "83324-135",
                "41163-883",
                "0363-1173"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DOCUSATE SODIUM",
                "SENNOSIDES"
              ],
              "rxcui": [
                "998740",
                "1791612"
              ],
              "spl_id": [
                "e053e3ff-8a66-468f-9065-3e8b05041b52",
                "a32c5770-8ca1-4930-8063-573e5f19e747",
                "7645f18f-a849-4fc6-9661-0591c511bae6",
                "587aa5d6-069c-7619-e063-6394a90a8145",
                "441ef4c5-4902-159d-e063-6394a90aebd0",
                "536f49ab-7030-6114-e063-6394a90ad18e",
                "08bf70ec-89e8-36e5-e063-6294a90a6772",
                "36bb75f0-b291-4515-b49f-9ad4d80be637",
                "708c9ffc-fcc8-49c8-ab66-8cdbd2256bfb",
                "4279edd4-11aa-afa7-e063-6294a90a4009"
              ],
              "spl_set_id": [
                "3984f4aa-2794-410c-ae9e-ee5bc31c0470",
                "b03e1500-0a4f-4e3d-a897-d7781fd5f791",
                "acb40b29-5fd5-4864-b6bf-4102e47a1683",
                "0be906d8-3db5-4218-bbdf-f1d126007990",
                "9c87759f-3856-4f30-b5ea-4b37ed90f18c",
                "6cd22881-db60-9045-e053-2991aa0ae08a",
                "9deaf264-6af0-40ba-e053-2a95a90ada0e",
                "9c986ca8-d540-49c1-b092-94c1bf837c07",
                "3f519d42-72bc-4cc3-a43f-14b94a10eb9a",
                "765bfd9b-7a21-4315-9add-cf13007722d5"
              ],
              "package_ndc": [
                "36800-783-60",
                "36800-783-12",
                "0363-0883-12",
                "0363-0883-60",
                "0363-0883-20",
                "21130-883-30",
                "83059-0120-6",
                "10135-669-01",
                "53329-989-62",
                "54257-089-02",
                "83324-135-60",
                "41163-883-30",
                "0363-1173-60"
              ],
              "unii": [
                "F05Q2T2JA0",
                "3FYP5M0IJX"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MARINOL",
            "drugstructuredosagenumb": "10",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DRONABINOL"
            },
            "openfda": {
              "application_number": [
                "NDA018651"
              ],
              "brand_name": [
                "MARINOL"
              ],
              "generic_name": [
                "DRONABINOL"
              ],
              "manufacturer_name": [
                "ThePharmaNetwork, LLC"
              ],
              "product_ndc": [
                "53097-568",
                "53097-569",
                "53097-570",
                "53097-571",
                "53097-572",
                "53097-573"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DRONABINOL"
              ],
              "rxcui": [
                "197634",
                "197635",
                "197636",
                "205641",
                "205642",
                "205645"
              ],
              "spl_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48"
              ],
              "spl_set_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "d0efeeec-640d-43c3-8f0a-d31324a11c68"
              ],
              "package_ndc": [
                "53097-568-60",
                "53097-569-60",
                "53097-570-60",
                "53097-571-60",
                "53097-572-60",
                "53097-573-60"
              ],
              "nui": [
                "N0000175782",
                "M0003267"
              ],
              "pharm_class_epc": [
                "Cannabinoid [EPC]"
              ],
              "pharm_class_cs": [
                "Cannabinoids [CS]"
              ],
              "unii": [
                "7J8897W37S"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "COLACE",
            "drugstructuredosagenumb": "100",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DOCUSATE SODIUM"
            },
            "openfda": {
              "application_number": [
                "M007"
              ],
              "brand_name": [
                "COLACE"
              ],
              "generic_name": [
                "DOCUSATE SODIUM"
              ],
              "manufacturer_name": [
                "Atlantis Consumer Healthcare, Inc."
              ],
              "product_ndc": [
                "67618-101",
                "67618-111"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DOCUSATE SODIUM"
              ],
              "rxcui": [
                "1115005",
                "1247756",
                "1247759",
                "1247761"
              ],
              "spl_id": [
                "650714ee-2cec-42c9-8631-b3f8ebc7348f",
                "ec10da1a-de65-47d1-ae30-07ad97469e73"
              ],
              "spl_set_id": [
                "7793fced-e8ee-44e2-b212-dd2a59a5f462",
                "a1591da0-a1a9-9583-3cf5-788b8fee3814"
              ],
              "package_ndc": [
                "67618-101-10",
                "67618-101-30",
                "67618-101-60",
                "67618-101-01",
                "67618-101-52",
                "67618-101-51",
                "67618-101-25",
                "67618-111-28",
                "67618-111-42",
                "67618-111-60",
                "67618-111-10"
              ],
              "unii": [
                "F05Q2T2JA0"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "LONSURF",
            "drugbatchnumb": "UNKNOWN",
            "drugstructuredosagenumb": "65",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "(3) 15 MG AND (1) 20 MG TWICE DAILY",
            "drugadministrationroute": "048",
            "drugindication": "COLORECTAL CANCER METASTATIC",
            "drugstartdateformat": "102",
            "drugstartdate": "20190806",
            "actiondrug": "5",
            "drugadditional": "3",
            "activesubstance": {
              "activesubstancename": "TIPIRACIL HYDROCHLORIDE\\TRIFLURIDINE"
            },
            "openfda": {
              "application_number": [
                "NDA207981"
              ],
              "brand_name": [
                "LONSURF"
              ],
              "generic_name": [
                "TRIFLURIDINE AND TIPIRACIL"
              ],
              "manufacturer_name": [
                "Taiho Pharmaceutical Co., Ltd."
              ],
              "product_ndc": [
                "64842-1020",
                "64842-1025"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "TRIFLURIDINE",
                "TIPIRACIL HYDROCHLORIDE"
              ],
              "rxcui": [
                "1670311",
                "1670316",
                "1670322",
                "1670324"
              ],
              "spl_id": [
                "15b86e86-8940-44e3-921c-2e0b97180ea1"
              ],
              "spl_set_id": [
                "f5beed22-d71d-4c0d-8dca-2c7317d65d85"
              ],
              "package_ndc": [
                "64842-1025-1",
                "64842-1025-2",
                "64842-1025-3",
                "64842-1020-1",
                "64842-1020-2",
                "64842-1020-3"
              ],
              "nui": [
                "N0000175459",
                "N0000175466",
                "N0000175595",
                "N0000000233"
              ],
              "pharm_class_epc": [
                "Nucleoside Analog Antiviral [EPC]",
                "Nucleoside Metabolic Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Nucleic Acid Synthesis Inhibitors [MoA]"
              ],
              "unii": [
                "4H59KLQ0A4",
                "RMW9V5RW38"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "GAS-X",
            "drugstructuredosagenumb": "125",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DIMETHICONE"
            },
            "openfda": {
              "application_number": [
                "M001",
                "M002"
              ],
              "brand_name": [
                "GAS-X TOTAL RELIEF MAXIMUM STRENGTH",
                "GAS-X MAXIMUM STRENGTH SOFTGELS",
                "GAS-X EXTRA STRENGTH SOFTGELS",
                "GAS-X EXTRA STRENGTH",
                "GAS-X ULTRA STRENGTH ANTIGAS SOFTGELS",
                "GAS-X ULTIMATE STRENGTH SOFTGELS"
              ],
              "generic_name": [
                "CALCIUM CARBONATE, SIMETHICONE",
                "SIMETHICONE"
              ],
              "manufacturer_name": [
                "Haleon US Holdings LLC"
              ],
              "product_ndc": [
                "0067-0119",
                "0067-6283",
                "0067-0118",
                "0067-6275",
                "0067-0129",
                "0067-6274",
                "0067-8075",
                "0067-0117"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CALCIUM CARBONATE",
                "DIMETHICONE",
                "DIMETHICONE, UNSPECIFIED"
              ],
              "rxcui": [
                "1741562",
                "2590817",
                "412111",
                "2119393",
                "198852",
                "210299",
                "210295",
                "314221",
                "252294",
                "860055",
                "2477951",
                "2716712"
              ],
              "spl_id": [
                "155b17da-8661-a6be-e063-6394a90abece",
                "155aa0c5-6407-ee86-e063-6294a90a1c4d",
                "39fef47c-14de-b3b3-e063-6294a90afc1d",
                "0f32f8eb-2579-4a26-99d5-a45c50bf5bdb",
                "13305fe6-fce2-4568-8722-d927e2545baf",
                "155b4b66-48c2-b2e8-e063-6394a90a8f12",
                "3597dc18-fb8f-a1e3-e063-6394a90a04ea",
                "b5d94cf5-198b-4797-9de7-3014bcc12202"
              ],
              "spl_set_id": [
                "62fc0a91-c44f-4546-a472-c183a2d95486",
                "45d1e373-0717-47df-9160-619c451666f4",
                "edb0f11a-bdb7-484d-9257-09ff47b0fca4",
                "fa4a3b07-591b-4445-aa67-b17ba1e67d5c",
                "f553374b-c20e-4c92-a8c0-cef0aeda8d1c",
                "ee9a8404-0653-433f-90e5-7ac69bdab8df",
                "24b777e5-f0b5-400d-8ca9-ae0c04b8503b",
                "7ce312ca-542b-4bc0-97b5-f65279e1e84c"
              ],
              "package_ndc": [
                "0067-0119-01",
                "0067-6283-01",
                "0067-6283-02",
                "0067-0118-03",
                "0067-0118-02",
                "0067-0118-01",
                "0067-6275-30",
                "0067-6275-10",
                "0067-6275-20",
                "0067-6275-50",
                "0067-6275-72",
                "0067-6275-82",
                "0067-6275-01",
                "0067-0129-48",
                "0067-0129-18",
                "0067-0129-27",
                "0067-6274-18",
                "0067-6274-50",
                "0067-8075-20",
                "0067-0117-18",
                "0067-0117-27",
                "0067-0117-48",
                "0067-0117-49",
                "0067-0117-01"
              ],
              "nui": [
                "N0000010282"
              ],
              "pharm_class_pe": [
                "Skin Barrier Activity [PE]"
              ],
              "unii": [
                "H0G9379FGK",
                "92RU3N3Y1O"
              ]
            }
          }
        ]
      }
    }
  ]
}